IXICO

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers unparalleled precision in predicting clinical outcomes at future time points. The platform allows for designing smaller, more efficient studies, enhancing decision-making with digital twins, and identifying sensitive clinical outcomes. Unlearn.ai specializes in accelerating clinical development in various fields like neuroscience, immunology, and metabolic diseases.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HOPPR is a medical-grade platform that accelerates the development of tailored applications to enhance clinical care and optimize workflows. The platform streamlines AI development in medical imaging, prioritizes data security and privacy, and offers diverse datasets across modalities, anatomies, demographics, and geographies. HOPPR empowers faster prototyping, hypothesis testing, and scalable applications for research and medical imaging services, addressing the growing crisis in medical imaging by enabling partners to rapidly develop solutions that improve patient care, enhance operational efficiency, and increase clinician satisfaction.

Decode Health is an AI and analytics platform that accelerates precision healthcare by supporting healthcare teams in launching machine learning and advanced analytics projects. The platform collaborates with pharmaceutical companies to enhance patient selection, biomarker identification, diagnostics development, data asset creation, and analysis. Decode Health offers modules for biomarker discovery, patient recruitment, next-generation sequencing, data analysis, and clinical decision support. The platform aims to provide fast, accurate, and actionable insights for acute and chronic disease management. Decode Health's custom-built modules are designed to work together to solve complex data problems efficiently.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

Radiology Business is an AI tool designed to provide insights and solutions for professionals in the radiology field. The platform covers a wide range of topics including management, imaging, technology, and conferences. It offers news, analysis, and resources to help radiologists stay informed and make informed decisions. Radiology Business aims to leverage artificial intelligence to improve workflow efficiency and enhance the overall experience in the radiology ecosystem.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Gemini AI is a cutting-edge AI and ML solutions provider that focuses on accelerating innovation through artificial intelligence. The company leads the revolution of artificial intelligence for augmented intelligence, leveraging the power of AI and ML to solve complex problems in various domains such as computer vision, geospatial science, human health, and integrative technologies. Gemini AI offers services in data and sensors, modeling, and deployment, providing actionable insights and predictive models trained by human input. The company aims to augment human intelligence through discovery, innovation, transparency, and optimization.

The website OpenLife.ai is an AI tool that focuses on various aspects of healthcare, including medical AI, ambient clinical intelligence, clinical documentation integrity, healthcare analytics, patient engagement, radiology solutions, and more. It offers insights, news, and resources related to the application of artificial intelligence in the healthcare industry.

iCAD is an AI-powered application designed for cancer detection, specifically focusing on breast cancer. The platform offers a suite of solutions including Detection, Density Assessment, and Risk Evaluation, all backed by science, clinical evidence, and proven patient outcomes. iCAD's AI-powered solutions aim to expose the hiding place of cancer, providing certainty and peace of mind, ultimately improving patient outcomes and saving more lives.

SOMA is a Research Automation Platform designed to accelerate medical innovation by automating the process of analyzing medical research articles. It extracts important concepts, identifies causal and associative relationships, and organizes information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like drug repurposing, target discovery, and literature review efficiently. The platform offers API access, community support, and freemium sign-up options.

Dimensions AI is an advanced scientific research database that provides a suite of research applications and time-saving solutions for intelligent discovery and faster insight. It hosts the largest collection of interconnected global research data, including publications, clinical trials, patents, policy documents, grants, datasets, and online citations. The platform offers easy-to-understand visualizations, purpose-built applications, and integrated AI technology to speed up research interpretation and analysis. Dimensions is designed to propel research by connecting the dots across the research ecosystem and saving researchers hours of time.

Astra Health is a leading multilingual AI assistant designed for clinicians to automate clinical documentation, empower clinicians with medical notes creation solutions using generative AI, and provide features like ambient listening mode, instant notes generation, and custom templates. The application is trusted by thousands of clinicians and is known for its ethical and safe practices in data security. Astra Health AI has transformed clinical note-taking, allowing clinicians to focus more on patient care and improve efficiency in consultations.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

IXICO is a precision analytics company specializing in intelligent insights in neuroscience. They offer a range of services for drug development analytics, imaging operations, and post-marketing consultancy. With a focus on technology and innovation, IXICO provides expertise in imaging biomarkers, radiological reads, volumetric MRI, PET & SPECT, and advanced MRI. Their TrialTracker platform and Assessa tool utilize innovation and AI for disease modeling and analysis. IXICO supports biopharmaceutical companies in CNS clinical research with cutting-edge neuroimaging techniques and AI technology.

SOMA is a Research Automation Platform designed to accelerate medical innovation by automating the process of analyzing medical research articles. It extracts important concepts, identifies causal and associative relationships, and organizes information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like drug repurposing, target discovery, and literature review efficiently. The platform offers API access, community support, and freemium sign-up options.

The Unlearn Platform is an AI-powered platform that streamlines clinical trials by creating digital twins of patients. It offers unparalleled precision in predicting clinical outcomes at future time points. The platform allows for designing smaller, more efficient studies, enhancing decision-making with digital twins, and identifying sensitive clinical outcomes. Unlearn.ai specializes in accelerating clinical development in various fields like neuroscience, immunology, and metabolic diseases.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Ignota Labs is a technology company focused on rescuing failing drugs and bringing new life to abandoned projects, ultimately providing hope to patients. The company utilizes a proprietary AI model, SAFEPATH, which applies deep learning to bioinformatics and cheminformatics datasets to solve drug safety issues. Ignota Labs aims to identify promising drug targets, address safety problems in clinical trials, and accelerate the delivery of therapeutically effective drugs to patients.

MeDA School is an educational platform dedicated to promoting and nurturing talents in the field of Medical Artificial Intelligence (AI). The platform aims to establish a solid foundation for intelligent and precision medical talent pools in Taiwan and globally. MeDA School facilitates interaction and communication among members of the intelligent medical ecosystem, fostering deep understanding and trust in the operation and tasks of medical AI. The platform offers a blend of virtual and physical courses, inviting domain experts to share cutting-edge knowledge and integrating interdisciplinary knowledge to be practically applied in various fields.